Geode Capital Management, LLC Bicycle Therapeutics PLC Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Geode Capital Management, LLC holds 40,412 shares of BCYC stock, worth $329,761. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,412
Previous 21,377
89.04%
Holding current value
$329,761
Previous $181,000
54.7%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BCYC
# of Institutions
118Shares Held
42.1MCall Options Held
111KPut Options Held
16.6K-
Baker Bros. Advisors LP New York, NY10.9MShares$88.8 Million0.77% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$28.2 Million6.5% of portfolio
-
Armistice Capital, LLC New York, NY2.8MShares$22.8 Million0.34% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.66MShares$21.7 Million0.12% of portfolio
-
Siren, L.L.C. New York, NY2.01MShares$16.4 Million0.72% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $242M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...